Nachrichten zur Rhythm Pharmaceuticals Inc. Aktie

Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Study of Setmelanotide in Patients Between 2 and 5 Years Old in The Lancet Diabetes & Endocrinology

BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused…

Hungerkontrolle: Der Kampf gegen Adipositas

Rhythm Pharmaceuticals ist ein biopharmazeutisches Unternehmen, das sich auf die Entwicklung innovativer Therapien zur Behandlung seltener genetischer Adipositasstörungen konzentriert. Das…

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

BOSTON, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused…

Rhythm Pharmaceuticals, Inc. (RYTM) Q3 2024 Earnings Call Transcript

…

Rhythm Pharmaceuticals and Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome

BOSTON and LONDON, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) and Axovia Therapeutics Ltd. today…

Rhythm Pharmaceuticals, Inc. (RYTM) Q2 2024 Earnings Call Transcript

…

Rhythm Pharmaceuticals to Report Second Quarter 2024 Financial Results on Tuesday, August 6, 2024

BOSTON, July 23, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on…

Rhythm Pharmaceuticals, Inc (RYTM) Q1 2024 Earnings Call Transcript

…

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

BOSTON, April 16, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on…

Rhythm Pharmaceuticals CTO sells shares worth over $735k By Investing.com

Rhythm Pharmaceuticals CTO sells shares worth over $735k…

Rhythm Pharmaceuticals executive sells shares worth over $700k By Investing.com

Rhythm Pharmaceuticals executive sells shares worth over $700k…

Rhythm Pharmaceuticals CFO sells shares worth over $600k By Investing.com

Rhythm Pharmaceuticals CFO sells shares worth over $600k…

Rhythm Pharmaceuticals exec sells $627,520 in stock By Investing.com

Rhythm Pharmaceuticals exec sells $627,520 in stock…

Earnings call: Rhythm Pharmaceuticals reports transformative year, eyes 2025 By Investing.com

Earnings call: Rhythm Pharmaceuticals reports transformative year, eyes 2025…

Rhythm Pharmaceuticals, Inc. (RYTM) Q4 2023 Earnings Call Transcript

…

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

BOSTON, Jan. 12, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on…

Rhythm Pharmaceuticals and LG Chem Life Sciences Enter Agreement for Rhythm to Acquire Global Rights to Oral MC4R Agonist LB54640

-- LB54640 has shown targeted effect on MC4 receptor without hyperpigmentation -- -- Rhythm to advance LB54640 in two Phase…

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

BOSTON, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on…

Rhythm Pharmaceuticals, Inc. (RYTM) Q3 2023 Earnings Call Transcript

…

Rhythm Pharmaceuticals, Inc. 2023 Q3 - Results - Earnings Call Presentation

…

Rhythm Pharmaceuticals to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

BOSTON, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming…

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

BOSTON, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on…

Rhythm Pharmaceuticals Announces Six Abstracts to be Presented at The Obesity Society’s Annual Meeting at ObesityWeek ®

BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on…

Rhythm Pharmaceuticals Presents New Data at ESPE 2023

BOSTON, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on…

Rhythm Pharmaceuticals Receives Orphan Drug Designation from European Medicines Agency for Setmelanotide for Treatment of Acquired Hypothalamic Obesity

BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on…

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

BOSTON, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on…

Rhythm Pharmaceuticals to Present at Investor Conferences in September

BOSTON, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on…

Insiderhandel: EVP, Head of North America verkauft Aktien von Rhythm Pharmaceuticals im Wert von 42.366$

Lee, Jennifer Kayden - Vorstand - Tag der Transaktion: 2023-08-09...…

Insiderhandel: EVP, Head of North America verkauft Aktien von Rhythm Pharmaceuticals im Wert von 271.347$

Lee, Jennifer Kayden - Vorstand - Tag der Transaktion: 2023-08-07...…

Form 8-K RHYTHM PHARMACEUTICALS, For: Aug 04

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

BOSTON, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on…

Form 8-K RHYTHM PHARMACEUTICALS, For: Jul 28

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Rhythm Pharma surges on strong Q2 sales; BofA upgrades

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Rhythm Pharmaceuticals Shares Jump After 2Q Revenue Tops Expectations

Rhythm Pharmaceuticals Shares Jump After 2Q Revenue Tops Expectations...…

Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q2 Loss, Tops Revenue Estimates

Rhythm Pharmaceuticals, Inc. (RYTM) delivered earnings and revenue surprises of -2.50% and 29.96%, respectively, for the quarter ended June 2023.…

Rhythm Pharmaceuticals GAAP EPS of -$0.82 misses by $0.04, revenue of $19.22M beats by $4.19M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Rhythm Pharmaceuticals GAAP EPS of -$0.82 misses by $0.04, revenue of $19.2M beats by $4.17M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K RHYTHM PHARMACEUTICALS, For: Aug 01

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Rhythm Pharmaceuticals Q2 2023 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Chief Human Resources Officer verkauft Aktien von Rhythm Pharmaceuticals im Wert von 16.405$

Cramer, Pamela J. - Vorstand - Tag der Transaktion: 2023-07-26...…

Rhythm Pharmaceuticals to Report Second Quarter 2023 Financial Results on Tuesday, August 1, 2023

BOSTON, July 17, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming…

Rhythm Pharmaceuticals Announces New Employment Inducement Grants

BOSTON, July 13, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on…

Form 8-K RHYTHM PHARMACEUTICALS, For: Jun 21

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Rhythm Pharmaceuticals Presents Data Demonstrating BMI Reduction in Patients with Hypothalamic Obesity Treated with Setmelanotide over Six Months at ENDO 2023

-- Mean BMI reduction of 21.0% from baseline observed in 13 patients at six months, showing progression from 16.8% mean…

dpa-AFX ProFeed